Natixis Advisors LLC boosted its holdings in shares of Humana Inc. (NYSE:HUM – Free Report) by 1.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 96,375 shares of the insurance provider’s stock after purchasing an additional 1,023 shares during the quarter. Natixis Advisors LLC owned approximately 0.08% of Humana worth $30,526,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. CarsonAllaria Wealth Management Ltd. increased its holdings in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after acquiring an additional 39 shares in the last quarter. Creative Financial Designs Inc. ADV increased its stake in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares in the last quarter. Atwood & Palmer Inc. acquired a new position in shares of Humana during the 3rd quarter worth about $29,000. Hantz Financial Services Inc. purchased a new position in Humana in the 2nd quarter valued at about $35,000. Finally, Family Firm Inc. acquired a new stake in Humana in the 2nd quarter worth about $37,000. 92.38% of the stock is owned by institutional investors and hedge funds.
Humana Stock Performance
NYSE:HUM opened at $275.67 on Monday. The firm’s fifty day moving average price is $281.36 and its 200 day moving average price is $331.94. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $527.18. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market cap of $33.19 billion, a price-to-earnings ratio of 24.42, a price-to-earnings-growth ratio of 2.17 and a beta of 0.52.
Humana Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is currently 31.36%.
Wall Street Analyst Weigh In
HUM has been the topic of a number of research analyst reports. Oppenheimer lowered their price target on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research note on Thursday, October 3rd. Royal Bank of Canada dropped their target price on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. TD Cowen raised their price target on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research note on Thursday, October 3rd. Finally, KeyCorp started coverage on shares of Humana in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $315.86.
Check Out Our Latest Research Report on Humana
About Humana
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles
- Five stocks we like better than Humana
- Buy P&G Now, Before It Sets A New All-Time High
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Where to Find Earnings Call Transcripts
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.